Lifestance Health Group Inc

LifeStance Health Group describes itself as one of the largest outpatient mental health providers in the U.S. Outpatient means patients come in for appointments and do not stay in a hospital. As of December 31, 2025, it employed 8,040 licensed clinicians in 33 states through its subsidiaries and supported practices. They include psychiatrists, psychologists, therapists and advanced practice nurses. They treat conditions such as anxiety, depression, bipolar disorder and post-traumatic stress disorder. Patients can see them in person at leased centers or by video. In 2025, they saw more than 1.0 million patients across about 9.0 million visits.

LifeStance is paid per visit, mostly by health insurers. It is "in-network" with many of them, which means it has agreed rates and patients pay less out of pocket. In 2025, 90% of revenue came from patients with commercial insurance, 5% from government programs, 4% from patients paying their own way and 1% from non-patient services. Two insurers stand out: Elevance Health accounted for 15% of revenue and UnitedHealthcare for 14%.

In some states, clinicians work for LifeStance subsidiaries. In others, they work for "supported practices" that LifeStance manages under long-term contracts but does not own, and LifeStance earns management fees from them. It also runs more than 13 integrated care programs with primary care doctors and specialists, and sometimes places its clinicians at their sites. Revenue reached $1.42 billion in 2025, up 13.9%.

• In Q2 FY2026 (ended Jun 30, 2026), revenue was $435.4M, up 26.1% from a year earlier, and net income was $23.6M.
• For fiscal 2025, revenue was $1.42B (+13.9% year over year; +20.9% a year from FY2021 to FY2025) with a 0.7% net margin.

• Over FY2021–FY2025: $0.00 in buybacks and $0.00 in dividends.
• The company pays no regular dividend.
• Shares outstanding changed +2.1% from Aug 12, 2021 to Jul 29, 2026.

Rank among 1514 US companies

Market value at each year end

Lifestance Health Group’s market value went from $1.86B at the end of 2022 to $5.12B on Oct 28, 2026, about 2.8 times as much; since the end of 2025 it is up 87%.

Form 4 filings from 2025-10-29 to 2026-10-29 (25 read): 0 open-market purchases and 17 sales ($669.2M), 6 of them under pre-arranged 10b5-1 trading plans.

Large shareholders (13G filings)

ETFs with the most weight in LFST

1. Insurers set most of its prices. In 2025, 90% of revenue came from patients with commercial insurance. If insurers cut rates, drop coverage or leave LifeStance out of narrower networks, revenue could fall faster than costs like clinician pay.
2. Heavy reliance on two big insurers. Elevance Health accounted for 15% of 2025 revenue and UnitedHealthcare for 14%. A rate cut or lost in-network status with either one could hurt more than a change at a smaller insurer.
3. Growth depends on hiring clinicians. LifeStance grows by hiring clinicians, and insurers must approve each one before their visits can be billed. Competition for clinicians could raise pay, slow hiring and squeeze already thin profits.
4. Telehealth rules and lower virtual pay. Patients can choose video visits instead of in-person ones. Telehealth rules are still evolving and could tighten. Insurers may also pay less for virtual visits, which would reduce revenue.
5. Relies on practices it does not own. In some states, clinicians work for "supported practices" that LifeStance manages under long-term contracts but does not own. A broken relationship or a legal challenge to these arrangements could harm the business.
6. Fast growth, very thin profits. Revenue grew about 21% a year from 2021 to 2025. But the company lost money each year from 2021 to 2024, and 2025 profit was just 0.7% of revenue. Slower growth could erase it.

• Oct 16, 2026 Executive or board change
• Sep 11, 2026 Other company announcement
• Aug 6, 2026 Quarterly results released; Investor presentation or announcement; Other company announcement
• Jul 7, 2026 Executive or board change
• Jun 4, 2026 Shareholder vote results
• May 12, 2026 Other company announcement
• May 7, 2026 Quarterly results released; Investor presentation or announcement
• Mar 11, 2026 Executive or board change
• Mar 2, 2026 Other company announcement
• Feb 25, 2026 Quarterly results released; Executive or board change; Investor presentation or announcement; Other company announcement

LifeStance pays no dividend, and its 10-K says it does not expect to pay any for the foreseeable future. It also bought back no shares from 2021 through 2025. Instead, the share count rose 2.1% between August 12, 2021 and July 29, 2026, so each share owns a slightly smaller slice of the company. For an income investor, returns come only from the share price, and the only way to get cash is to sell shares.

The price history reviewed here covers about four years. It does not show how the stock held up in the 2008 financial crisis, the 2020 COVID crash or the 2022 bear market. Within that span, the stock fell as much as 59.7% from a peak, yet it gained 162.5% in the year to October 28, 2026. Single stocks carry more risk than diversified funds, because one company's setbacks can sink the whole investment.